Cue Biopharma, Inc.
CUE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645460
In the last 90 days, Cue Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $52.2M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Cue Biopharma, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 52 | 49 | −3 |
| Shares | 18.1M | 21.8M | +3.76M (+20.8%) |
| Value | $13.0M | $6.67M | −$6.31M (−48.6%) |
New holders (8)
Institutions that held Cue Biopharma, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Lion Point Capital, LP | 2,202,854 | $672.8K | 3.48% |
| Jane Street Group, LLC | 69,793 | $21.3K | 0.00% |
| Miramontes Capital, LLC | 26,041 | $7.95K | 0.00% |
| HRT Financial LP | 20,863 | $6.00K | 0.00% |
| HighTower Advisors, LLC | 10,929 | $3.34K | 0.00% |
| New Millennium Group LLC | 5,750 | $1.76K | 0.00% |
| Jones Financial Companies LLLP | 400 | $122 | 0.00% |
| Torren Management, LLC | 324 | $99 | 0.00% |
Sold out (11)
Institutions that held Cue Biopharma, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Squarepoint Ops LLC | 85,800 | $61.7K |
| Two Sigma Securities, LLC | 39,514 | $28.4K |
| Navalign, LLC | 25,000 | $18.0K |
| Virtu Financial LLC | 15,079 | $11.0K |
| XTX Topco Ltd | 14,741 | $10.6K |
| Tower Research Capital LLC (TRC) | 10,135 | $7.28K |
| Mather Group, LLC. | 1,000 | $719 |
| Sunbelt Securities, Inc. | 237 | $170 |
| Advisory Services Network, LLC | 200 | $144 |
| Citigroup Inc | 132 | $95 |
| SBI Securities Co., Ltd. | 1 | $1 |